Concepedia

Peter Hoffmann

PH

Statistics

Publications

56

Citations

2.1K

H-Index

22

Active since

1978

Affiliations

Martin Luther University Halle-Wittenberg(Current)

Novartis (United States)

Novartis (Switzerland)

Sanofi (France)

Luther University

Peter Hoffmann is an author at Martin Luther University Halle-Wittenberg specializing in pharmacology, medicine, and clinical pharmacology.

ORCID

Publications per year

1978–2022

56

Publications

56

Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide

J. M. Herbert, Jean-P. Hérault, A. Bernat et al. · Blood · 1998 · 206 citations

, , +9

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text

, , +10

Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells

Martin Traebert, Bérengère Dumotier, Lothar Meister et al. · European Journal of Pharmacology · 2003 · 158 citations

, , +9

Blinded Test in Isolated Female Rabbit Heart Reliably Identifies Action Potential Duration Prolongation and Proarrhythmic Drugs: Importance of Triangulation, Reverse Use Dependence, and Instability

Luc M. Hondeghem, Peter Hoffmann · Journal of Cardiovascular Pharmacology · 2003 · 134 citations

, , +10

Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics

Hugo M. Vargas, Alan Bass, Alexander Breidenbach et al. · Journal of Pharmacological and Toxicological Methods · 2008 · 124 citations

, , +11

1–5 of 56